# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Nov 14, 2022

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2022-11-14
- Accepted by EDGAR: Nov 14, 2022, 21:09 ET
- Period: 2022-11-10
- Accession: 0001104659-22-118535
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000110465922118535/tm2230297d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000110465922118535/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000110465922118535/tm2230297d1_8k.htm

Filed Nov 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-118535. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.